The effect of empagliflozin on the development of chronic heart failure after myocardial infarction according to a 12-month prospective study

The effect of empagliflozin on the development of chronic heart failure after myocardial infarction according to a 12-month prospective study

BACKGROUND: Although the positive cardiovascular effect of empagliflozin has been established, its influence on the formation of heart failure (HF) in patients with type 2 diabetes mellitus (T2D) after myocardial infarction (MI) remains unknown. AIM: To study the effect of empagliflozin on the forma...

Full description

Bibliographic Details
Main Authors: Alexey A. Nekrasov, Elena S. Timoschenko, Leonid G. Strongin, Tatyana A. Nekrasova, Anastasiya A. Baranova, Svetlana N. Botova, Michail V. Timoschenko, Mariya A. Yaroslavtseva
Format: Article
Language:English
Published: Endocrinology Research Centre 2019-10-01
Series:Сахарный диабет
Subjects:
empagliflozin
myocardial infarction
the formation of chronic heart failure
Online Access:https://www.dia-endojournals.ru/jour/article/view/10099

Internet

https://www.dia-endojournals.ru/jour/article/view/10099

Similar Items